Page last updated: 2024-08-26

phenylacetylglutamine and Coronary Stenosis

phenylacetylglutamine has been researched along with Coronary Stenosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, H; Liu, S; Liu, Y; Qu, H; Song, X; Zhao, Z1

Other Studies

1 other study(ies) available for phenylacetylglutamine and Coronary Stenosis

ArticleYear
Phenylacetylglutamine is associated with the degree of coronary atherosclerotic severity assessed by coronary computed tomographic angiography in patients with suspected coronary artery disease.
    Atherosclerosis, 2021, Volume: 333

    Topics: Computed Tomography Angiography; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Glutamine; Humans; Plaque, Atherosclerotic; Predictive Value of Tests; Prospective Studies; Registries; Severity of Illness Index; Tomography, X-Ray Computed

2021